Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer
Canadian Cancer Trials Group
Canadian Cancer Trials Group
National University Hospital, Singapore
OncoC4, Inc.
BeiGene
University of Arkansas
The Methodist Hospital Research Institute
Spanish Breast Cancer Research Group
Incyte Corporation
National Cancer Institute (NCI)
Western Regional Medical Center
Incyte Corporation
Hoffmann-La Roche
City of Hope Medical Center
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
University of Michigan Rogel Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Centre Georges Francois Leclerc
Pfizer
Hellenic Oncology Research Group
NeuTec Pharma